Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperoxia | 31 | 2025 | 78 | 6.150 |
Why?
|
| Lung | 27 | 2025 | 363 | 4.120 |
Why?
|
| Inflammation | 12 | 2019 | 608 | 3.050 |
Why?
|
| Bronchopulmonary Dysplasia | 11 | 2025 | 44 | 3.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 5 | 2019 | 100 | 2.130 |
Why?
|
| Animals, Newborn | 21 | 2025 | 178 | 1.700 |
Why?
|
| Docosahexaenoic Acids | 4 | 2016 | 91 | 1.680 |
Why?
|
| Lung Injury | 7 | 2018 | 32 | 1.530 |
Why?
|
| Mice | 37 | 2025 | 4473 | 1.370 |
Why?
|
| Mice, Inbred C3H | 17 | 2025 | 69 | 1.300 |
Why?
|
| Cyclooxygenase 2 | 5 | 2022 | 68 | 1.160 |
Why?
|
| MicroRNAs | 5 | 2017 | 281 | 1.100 |
Why?
|
| Animals | 40 | 2025 | 10080 | 1.100 |
Why?
|
| Diet, High-Fat | 2 | 2019 | 134 | 1.090 |
Why?
|
| Brain | 3 | 2016 | 710 | 1.030 |
Why?
|
| Pregnancy Complications | 3 | 2017 | 108 | 1.020 |
Why?
|
| Pulmonary Alveoli | 9 | 2018 | 33 | 1.000 |
Why?
|
| Pregnancy | 11 | 2019 | 1149 | 0.870 |
Why?
|
| Acute Lung Injury | 3 | 2022 | 12 | 0.850 |
Why?
|
| Lipopolysaccharides | 9 | 2022 | 156 | 0.830 |
Why?
|
| Disease Models, Animal | 14 | 2022 | 1405 | 0.820 |
Why?
|
| Obesity | 2 | 2019 | 654 | 0.780 |
Why?
|
| Thioredoxin Reductase 1 | 4 | 2019 | 13 | 0.730 |
Why?
|
| Arginase | 2 | 2018 | 6 | 0.660 |
Why?
|
| Jagged-1 Protein | 2 | 2016 | 6 | 0.650 |
Why?
|
| Profilins | 1 | 2018 | 2 | 0.630 |
Why?
|
| Cofilin 1 | 1 | 2018 | 2 | 0.630 |
Why?
|
| Microglia | 2 | 2016 | 58 | 0.630 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 28 | 0.620 |
Why?
|
| Lung Diseases | 3 | 2015 | 42 | 0.620 |
Why?
|
| Cell Adhesion Molecules | 1 | 2018 | 64 | 0.610 |
Why?
|
| Phosphoproteins | 1 | 2018 | 116 | 0.600 |
Why?
|
| Female | 20 | 2025 | 14635 | 0.600 |
Why?
|
| Actins | 1 | 2018 | 94 | 0.580 |
Why?
|
| DNA Methylation | 2 | 2016 | 149 | 0.570 |
Why?
|
| Dietary Supplements | 3 | 2015 | 221 | 0.570 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 33 | 0.570 |
Why?
|
| Epithelial Cells | 3 | 2019 | 241 | 0.570 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 28 | 0.560 |
Why?
|
| Infant, Premature | 2 | 2015 | 133 | 0.550 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2016 | 1 | 0.550 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2016 | 121 | 0.550 |
Why?
|
| Hepcidins | 1 | 2016 | 2 | 0.540 |
Why?
|
| Apoptosis | 2 | 2022 | 740 | 0.530 |
Why?
|
| Myelin Sheath | 1 | 2016 | 25 | 0.530 |
Why?
|
| Macrophages | 3 | 2016 | 279 | 0.520 |
Why?
|
| Prostaglandins | 3 | 2012 | 13 | 0.520 |
Why?
|
| Pneumonia | 2 | 2022 | 89 | 0.520 |
Why?
|
| Infant, Newborn | 7 | 2018 | 846 | 0.520 |
Why?
|
| Receptor, Notch1 | 1 | 2016 | 26 | 0.520 |
Why?
|
| Glutathione Disulfide | 3 | 2012 | 13 | 0.490 |
Why?
|
| Receptors, Notch | 1 | 2015 | 44 | 0.490 |
Why?
|
| Oxygen | 9 | 2025 | 230 | 0.480 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 142 | 0.470 |
Why?
|
| Thioredoxins | 3 | 2010 | 26 | 0.470 |
Why?
|
| Male | 15 | 2022 | 13022 | 0.470 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2011 | 177 | 0.460 |
Why?
|
| Oxidative Stress | 5 | 2025 | 635 | 0.460 |
Why?
|
| Neutrophil Infiltration | 2 | 2010 | 19 | 0.440 |
Why?
|
| Glutathione Reductase | 7 | 2020 | 17 | 0.440 |
Why?
|
| Oligodendroglia | 1 | 2013 | 13 | 0.440 |
Why?
|
| Fetal Growth Retardation | 1 | 2014 | 30 | 0.440 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2014 | 53 | 0.430 |
Why?
|
| Liver | 4 | 2012 | 424 | 0.420 |
Why?
|
| Gestational Age | 2 | 2012 | 141 | 0.400 |
Why?
|
| Glutathione | 8 | 2020 | 70 | 0.400 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 17 | 0.390 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2012 | 65 | 0.390 |
Why?
|
| RNA, Messenger | 6 | 2019 | 648 | 0.370 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2011 | 64 | 0.370 |
Why?
|
| Gene Expression Regulation | 5 | 2018 | 626 | 0.370 |
Why?
|
| Aurothioglucose | 5 | 2019 | 11 | 0.360 |
Why?
|
| Carrier Proteins | 2 | 2010 | 246 | 0.360 |
Why?
|
| NF-E2-Related Factor 2 | 3 | 2018 | 120 | 0.350 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 2010 | 16 | 0.340 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 110 | 0.340 |
Why?
|
| Phosphorylation | 3 | 2018 | 567 | 0.330 |
Why?
|
| Cells, Cultured | 4 | 2018 | 976 | 0.330 |
Why?
|
| Body Weight | 5 | 2016 | 248 | 0.310 |
Why?
|
| HMGB1 Protein | 2 | 2016 | 5 | 0.260 |
Why?
|
| Gene Expression | 2 | 2018 | 408 | 0.250 |
Why?
|
| Thioredoxin-Disulfide Reductase | 3 | 2016 | 14 | 0.250 |
Why?
|
| Promoter Regions, Genetic | 3 | 2016 | 331 | 0.250 |
Why?
|
| Selenium | 1 | 2025 | 17 | 0.240 |
Why?
|
| Cytokines | 2 | 2016 | 440 | 0.230 |
Why?
|
| Fibrosis | 3 | 2014 | 121 | 0.220 |
Why?
|
| Myocardium | 2 | 2017 | 179 | 0.220 |
Why?
|
| Smad2 Protein | 2 | 2014 | 17 | 0.210 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 3 | 2018 | 40 | 0.210 |
Why?
|
| Cell Count | 2 | 2013 | 85 | 0.200 |
Why?
|
| Signal Transduction | 3 | 2022 | 1379 | 0.190 |
Why?
|
| Neutrophils | 3 | 2012 | 179 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 3 | 2018 | 1496 | 0.190 |
Why?
|
| Humans | 14 | 2018 | 27119 | 0.190 |
Why?
|
| Chemokine CCL2 | 3 | 2022 | 45 | 0.180 |
Why?
|
| Tyrosine | 2 | 2010 | 91 | 0.170 |
Why?
|
| Arachidonate 5-Lipoxygenase | 2 | 2010 | 12 | 0.170 |
Why?
|
| Weaning | 1 | 2019 | 18 | 0.160 |
Why?
|
| Oxidation-Reduction | 2 | 2012 | 355 | 0.160 |
Why?
|
| Caspase 3 | 2 | 2022 | 57 | 0.160 |
Why?
|
| RNA, Long Noncoding | 2 | 2016 | 27 | 0.160 |
Why?
|
| Embryo, Mammalian | 2 | 2016 | 29 | 0.160 |
Why?
|
| Random Allocation | 1 | 2018 | 148 | 0.150 |
Why?
|
| Ornithine-Oxo-Acid Transaminase | 1 | 2018 | 3 | 0.150 |
Why?
|
| Ornithine Decarboxylase | 1 | 2018 | 9 | 0.150 |
Why?
|
| Enzyme Induction | 1 | 2018 | 28 | 0.150 |
Why?
|
| Desmin | 1 | 2017 | 2 | 0.150 |
Why?
|
| Connexin 43 | 1 | 2017 | 4 | 0.150 |
Why?
|
| Ventricular Pressure | 1 | 2017 | 6 | 0.150 |
Why?
|
| Myocardial Contraction | 1 | 2017 | 61 | 0.150 |
Why?
|
| Myosin Heavy Chains | 1 | 2017 | 22 | 0.150 |
Why?
|
| Ventricular Function, Left | 1 | 2017 | 101 | 0.140 |
Why?
|
| Antioxidants | 1 | 2019 | 220 | 0.140 |
Why?
|
| Coenzyme A | 2 | 2010 | 11 | 0.140 |
Why?
|
| Encephalitis | 1 | 2016 | 18 | 0.130 |
Why?
|
| Cell Line | 3 | 2016 | 681 | 0.130 |
Why?
|
| Sex Factors | 1 | 2017 | 452 | 0.130 |
Why?
|
| Maternal Exposure | 1 | 2016 | 17 | 0.130 |
Why?
|
| Coculture Techniques | 1 | 2016 | 54 | 0.130 |
Why?
|
| Heart Rate | 1 | 2017 | 375 | 0.130 |
Why?
|
| Behavior, Animal | 1 | 2016 | 107 | 0.130 |
Why?
|
| Autopsy | 1 | 2015 | 24 | 0.130 |
Why?
|
| DNA Modification Methylases | 1 | 2015 | 13 | 0.130 |
Why?
|
| Presenilin-2 | 1 | 2015 | 2 | 0.130 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2015 | 3 | 0.130 |
Why?
|
| Presenilin-1 | 1 | 2015 | 4 | 0.130 |
Why?
|
| Sex Characteristics | 1 | 2016 | 163 | 0.120 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 35 | 0.120 |
Why?
|
| Iron | 1 | 2016 | 107 | 0.120 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 60 | 0.120 |
Why?
|
| Time Factors | 2 | 2010 | 1570 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 589 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 66 | 0.120 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 153 | 0.120 |
Why?
|
| Cell Proliferation | 1 | 2018 | 774 | 0.120 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2014 | 3 | 0.110 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2014 | 4 | 0.110 |
Why?
|
| Smad3 Protein | 1 | 2014 | 10 | 0.110 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2014 | 40 | 0.110 |
Why?
|
| Fetal Development | 1 | 2014 | 21 | 0.110 |
Why?
|
| Interleukin-6 | 1 | 2015 | 189 | 0.110 |
Why?
|
| Secretoglobins | 1 | 2013 | 2 | 0.110 |
Why?
|
| Uteroglobin | 1 | 2013 | 5 | 0.110 |
Why?
|
| Annexin A1 | 1 | 2013 | 3 | 0.110 |
Why?
|
| Riboflavin | 2 | 2010 | 6 | 0.110 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2014 | 54 | 0.110 |
Why?
|
| Birth Weight | 1 | 2014 | 63 | 0.110 |
Why?
|
| Prostaglandin-E Synthases | 1 | 2013 | 6 | 0.110 |
Why?
|
| Lipocalins | 1 | 2013 | 3 | 0.110 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2013 | 8 | 0.110 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 134 | 0.100 |
Why?
|
| Age Factors | 3 | 2010 | 721 | 0.100 |
Why?
|
| Oxidants | 1 | 2012 | 30 | 0.100 |
Why?
|
| Hippocampus | 1 | 2013 | 186 | 0.100 |
Why?
|
| Risk Factors | 1 | 2017 | 2030 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2012 | 26 | 0.100 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2012 | 3 | 0.100 |
Why?
|
| Infant | 1 | 2015 | 966 | 0.100 |
Why?
|
| Extracellular Space | 1 | 2012 | 26 | 0.100 |
Why?
|
| Diet | 1 | 2014 | 226 | 0.100 |
Why?
|
| Chromatography, Liquid | 1 | 2012 | 75 | 0.100 |
Why?
|
| Reference Standards | 1 | 2012 | 54 | 0.100 |
Why?
|
| Ventricular Myosins | 1 | 2011 | 1 | 0.100 |
Why?
|
| Connexins | 1 | 2011 | 3 | 0.100 |
Why?
|
| Chemokines | 1 | 2012 | 73 | 0.100 |
Why?
|
| Models, Animal | 1 | 2012 | 129 | 0.100 |
Why?
|
| NADPH Oxidase 4 | 1 | 2011 | 8 | 0.100 |
Why?
|
| Escherichia coli Infections | 1 | 2012 | 45 | 0.100 |
Why?
|
| Major Histocompatibility Complex | 1 | 2011 | 28 | 0.100 |
Why?
|
| Linear Models | 1 | 2012 | 201 | 0.100 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 77 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2015 | 467 | 0.100 |
Why?
|
| NADPH Oxidases | 1 | 2011 | 69 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 128 | 0.090 |
Why?
|
| Phagocytosis | 1 | 2012 | 79 | 0.090 |
Why?
|
| Collagen | 1 | 2012 | 147 | 0.090 |
Why?
|
| Myocytes, Cardiac | 1 | 2011 | 61 | 0.090 |
Why?
|
| Echocardiography | 1 | 2011 | 108 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 113 | 0.090 |
Why?
|
| Proteins | 1 | 2013 | 245 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2012 | 187 | 0.090 |
Why?
|
| Logistic Models | 1 | 2012 | 398 | 0.090 |
Why?
|
| Heart Ventricles | 1 | 2011 | 133 | 0.090 |
Why?
|
| Phagocytes | 1 | 2010 | 15 | 0.090 |
Why?
|
| Staphylococcal Infections | 1 | 2012 | 81 | 0.090 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2010 | 28 | 0.090 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2010 | 11 | 0.090 |
Why?
|
| Dietary Fats | 1 | 2010 | 58 | 0.090 |
Why?
|
| Intestinal Mucosa | 1 | 2012 | 186 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 455 | 0.090 |
Why?
|
| Kidney | 1 | 2012 | 276 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2022 | 794 | 0.080 |
Why?
|
| Thromboxane B2 | 1 | 2009 | 2 | 0.080 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2009 | 2 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2010 | 152 | 0.080 |
Why?
|
| Prospective Studies | 1 | 2012 | 1219 | 0.080 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2007 | 2 | 0.070 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2007 | 2 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2009 | 241 | 0.070 |
Why?
|
| Ornithine | 1 | 2006 | 2 | 0.070 |
Why?
|
| Glutathione Peroxidase | 2 | 2019 | 19 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2025 | 331 | 0.050 |
Why?
|
| Caspase 9 | 1 | 2022 | 16 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2022 | 68 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 243 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2020 | 56 | 0.040 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 2 | 2010 | 5 | 0.040 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2019 | 25 | 0.040 |
Why?
|
| Organ Size | 2 | 2010 | 85 | 0.040 |
Why?
|
| Mitochondria | 1 | 2002 | 342 | 0.040 |
Why?
|
| Antirheumatic Agents | 1 | 2018 | 56 | 0.040 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2016 | 6 | 0.030 |
Why?
|
| Auranofin | 1 | 2016 | 5 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2016 | 21 | 0.030 |
Why?
|
| Heme Oxygenase-1 | 1 | 2016 | 36 | 0.030 |
Why?
|
| Free Radicals | 1 | 2014 | 39 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2013 | 212 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2012 | 115 | 0.020 |
Why?
|
| Riboflavin Deficiency | 1 | 2010 | 2 | 0.020 |
Why?
|
| Transgenes | 1 | 2010 | 59 | 0.020 |
Why?
|
| Lung Compliance | 1 | 2010 | 3 | 0.020 |
Why?
|
| Airway Resistance | 1 | 2010 | 4 | 0.020 |
Why?
|
| Peroxidase | 1 | 2010 | 38 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 58 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 2010 | 36 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 408 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 489 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2012 | 330 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 400 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2008 | 20 | 0.020 |
Why?
|
| Air | 1 | 2008 | 23 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 2008 | 18 | 0.020 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2007 | 5 | 0.020 |
Why?
|
| Phenotype | 1 | 2010 | 667 | 0.020 |
Why?
|
| Citrulline | 1 | 2006 | 3 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2006 | 39 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2006 | 55 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2002 | 168 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 187 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2002 | 546 | 0.010 |
Why?
|
| Aging | 1 | 2007 | 952 | 0.010 |
Why?
|
| Biomarkers | 1 | 2002 | 738 | 0.010 |
Why?
|
| Rats | 1 | 2002 | 1554 | 0.010 |
Why?
|